AgomAb Therapeutics
AGMB
#6470
Rank
A$1.09 B
Marketcap
A$22.42
Share price
2.89%
Change (1 day)
N/A
Change (1 year)

AgomAb Therapeutics (AGMB) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.27 Billion

According to AgomAb Therapeutics 's latest financial reports the company's total assets are A$0.27 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AgomAb Therapeutics - Total assets on balance sheet (from 2024 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.34 B24.24%
2023-12-31A$0.27 B74.55%
2022-12-31A$0.15 B21.32%
2021-12-31A$0.13 B